Selskabets formål er forskning, udvikling, fremstilling og kommercialisering af proteinbaserede lægemidler og hermed efter bestyrelsens skøn stående relateret virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -42.2 mio. | -43.8 mio. | 18 mio. | 13.5 mio. | 4 | |
CVR: 40594132
Previous names: CytoKi Pharma ApS
Compared to 998 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Company entered liquidation
Christian Ellebæk Elling left the board
Karen Ina Barbara Wagner left the board
Annegret Elisabeth De Baey-Diepolder left the board
Klaus Andreas Dugi left the board
Anders Hagstrøm joined as liquidator
Rasmus Jørgensen left as ADM. DIR.
Company entered liquidation
Companies in the same industry and area
companydata.dk